拮抗剂-话题@MedSci

#拮抗剂#

223篇内容 | 4459人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1511721, encodeId=eedc1511e21f8, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=Eur Heart J：导管消融房颤之前何时停止非维生素K拮抗剂口服抗凝药？, objectType=article, longId=157150, objectId=2c7815e1502e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2c7815e1502e, replyNumber=0, likeNumber=54, createdTime=2019-01-02, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2c7815e1502e, moduleTitle=Eur Heart J：导管消融房颤之前何时停止非维生素K拮抗剂口服抗凝药？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2c7815e1502e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511720, encodeId=97981511e20d7, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=Clinical Gastro H：长期接受肿瘤坏死因子拮抗剂治疗的患者乙型肝炎病毒再激活和肝毒性的发生率, objectType=article, longId=155520, objectId=b82d1555203b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b82d1555203b, replyNumber=0, likeNumber=17, createdTime=2018-12-11, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b82d1555203b, moduleTitle=Clinical Gastro H：长期接受肿瘤坏死因子拮抗剂治疗的患者乙型肝炎病毒再激活和肝毒性的发生率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b82d1555203b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511719, encodeId=93901511e193e, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=Chest：肥厚型心肌病合并房颤患者服用非维生素K拮抗剂的疗效和安全性, objectType=article, longId=154285, objectId=faa315428559, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=faa315428559, replyNumber=0, likeNumber=59, createdTime=2018-11-25, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=faa315428559, moduleTitle=Chest：肥厚型心肌病合并房颤患者服用非维生素K拮抗剂的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=faa315428559)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511718, encodeId=0d771511e1800, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=JAMA Intern Med：醛固酮受体拮抗剂或可有助于STEMI治疗, objectType=article, longId=150695, objectId=70ad150695fe, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=70ad150695fe, replyNumber=0, likeNumber=78, createdTime=2018-10-11, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=70ad150695fe, moduleTitle=JAMA Intern Med：醛固酮受体拮抗剂或可有助于STEMI治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=70ad150695fe)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511717, encodeId=44f01511e1784, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=血管紧张素Ⅱ受体拮抗剂在冠心病患者中的临床应用建议（2018）, objectType=article, longId=149484, objectId=739a149484ca, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=739a149484ca, replyNumber=0, likeNumber=21, createdTime=2018-09-25, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=739a149484ca, moduleTitle=血管紧张素Ⅱ受体拮抗剂在冠心病患者中的临床应用建议（2018）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=739a149484ca)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511716, encodeId=d3591511e164d, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=Stroke：非维生素K拮抗剂口服抗凝药降低房颤患者卒中风险再添新证, objectType=article, longId=149048, objectId=797d149048e3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=797d149048e3, replyNumber=0, likeNumber=54, createdTime=2018-09-19, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=797d149048e3, moduleTitle=Stroke：非维生素K拮抗剂口服抗凝药降低房颤患者卒中风险再添新证, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=797d149048e3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511715, encodeId=d15e1511e15d1, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=JACC：口服维生素K拮抗剂房颤患者的预后研究, objectType=article, longId=148904, objectId=e15e14890461, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e15e14890461, replyNumber=0, likeNumber=76, createdTime=2018-09-17, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e15e14890461, moduleTitle=JACC：口服维生素K拮抗剂房颤患者的预后研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e15e14890461)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511714, encodeId=7d421511e1419, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=Chest：溶血磷脂酸受体1拮抗剂用于治疗特发性肺纤维化的疗效, objectType=article, longId=148562, objectId=596414856268, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=596414856268, replyNumber=0, likeNumber=119, createdTime=2018-09-11, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=596414856268, moduleTitle=Chest：溶血磷脂酸受体1拮抗剂用于治疗特发性肺纤维化的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=596414856268)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511713, encodeId=de361511e136b, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=JAHA：维生素K拮抗剂的摄入会增加心血管疾病风险, objectType=article, longId=147682, objectId=519414e68290, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=519414e68290, replyNumber=0, likeNumber=72, createdTime=2018-08-31, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=519414e68290, moduleTitle=JAHA：维生素K拮抗剂的摄入会增加心血管疾病风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=519414e68290)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511712, encodeId=55221511e12fb, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=Med Sci Monit：ATN-161作为整合素α5β1拮抗剂通过促进新生血管内皮细胞凋亡抑制眼部新生血管形成, objectType=article, longId=147575, objectId=19e114e57567, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=19e114e57567, replyNumber=0, likeNumber=74, createdTime=2018-08-30, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=19e114e57567, moduleTitle=Med Sci Monit：ATN-161作为整合素α5β1拮抗剂通过促进新生血管内皮细胞凋亡抑制眼部新生血管形成, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=19e114e57567)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511711, encodeId=9feb1511e1197, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=JAMA Cardiol：腹部肥胖患者使用盐皮质激素受体拮抗剂效果更佳, objectType=article, longId=147323, objectId=22f514e32309, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=22f514e32309, replyNumber=0, likeNumber=60, createdTime=2018-08-25, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=22f514e32309, moduleTitle=JAMA Cardiol：腹部肥胖患者使用盐皮质激素受体拮抗剂效果更佳, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=22f514e32309)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511710, encodeId=7c3c1511e100f, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=Clin Gastroenterol Hepatol：肝硬化门静脉血栓形成服用维生素K拮抗剂出血风险知多少？, objectType=article, longId=145807, objectId=2e4114580e49, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2e4114580e49, replyNumber=0, likeNumber=23, createdTime=2018-08-05, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2e4114580e49, moduleTitle=Clin Gastroenterol Hepatol：肝硬化门静脉血栓形成服用维生素K拮抗剂出血风险知多少？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2e4114580e49)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511709, encodeId=cfad1511e0982, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=FDA批准**口服促性腺激素释放激素拮抗剂用于治疗子宫内膜异位症, objectType=article, longId=145231, objectId=e2f714523172, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e2f714523172, replyNumber=0, likeNumber=66, createdTime=2018-07-28, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e2f714523172, moduleTitle=FDA批准**口服促性腺激素释放激素拮抗剂用于治疗子宫内膜异位症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e2f714523172)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511708, encodeId=441b1511e085f, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=JAHA：盐皮质激素受体拮抗剂可改善部分心梗和心衰患者预后, objectType=article, longId=142704, objectId=9448142e04d8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9448142e04d8, replyNumber=0, likeNumber=80, createdTime=2018-07-09, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9448142e04d8, moduleTitle=JAHA：盐皮质激素受体拮抗剂可改善部分心梗和心衰患者预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9448142e04d8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511707, encodeId=12971511e0796, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=降压药分子长效钙拮抗剂都包含哪些药？, objectType=article, longId=141532, objectId=fadf141532de, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fadf141532de, replyNumber=0, likeNumber=63, createdTime=2018-06-26, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fadf141532de, moduleTitle=降压药分子长效钙拮抗剂都包含哪些药？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fadf141532de)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511706, encodeId=676f1511e06e8, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=JAMA Inter Med：无心衰ST段抬高型心梗：醛固酮受体拮抗剂也有获益, objectType=article, longId=139777, objectId=5604139e7704, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5604139e7704, replyNumber=0, likeNumber=73, createdTime=2018-06-03, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5604139e7704, moduleTitle=JAMA Inter Med：无心衰ST段抬高型心梗：醛固酮受体拮抗剂也有获益, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5604139e7704)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511705, encodeId=4b251511e056d, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=Fertil Steril：体外受精：GnRH拮抗剂治疗的更佳起始条件, objectType=article, longId=139059, objectId=74a51390599c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=74a51390599c, replyNumber=0, likeNumber=46, createdTime=2018-05-26, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=74a51390599c, moduleTitle=Fertil Steril：体外受精：GnRH拮抗剂治疗的更佳起始条件, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=74a51390599c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511704, encodeId=e29d1511e04b2, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=Liver Int：盐皮质激素受体拮抗剂—eplerenone，可能不是治疗人类免疫缺陷病毒感染人群肝脂肪变性的有效方法, objectType=article, longId=138073, objectId=26641380e318, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=26641380e318, replyNumber=0, likeNumber=41, createdTime=2018-05-15, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=26641380e318, moduleTitle=Liver Int：盐皮质激素受体拮抗剂—eplerenone，可能不是治疗人类免疫缺陷病毒感染人群肝脂肪变性的有效方法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=26641380e318)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511703, encodeId=26641511e038b, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=Hepatology：CC趋化因子受体拮抗剂能够改善NASH患者的肝纤维化, objectType=article, longId=137609, objectId=e6bc13e609a0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e6bc13e609a0, replyNumber=0, likeNumber=55, createdTime=2018-05-10, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e6bc13e609a0, moduleTitle=Hepatology：CC趋化因子受体拮抗剂能够改善NASH患者的肝纤维化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e6bc13e609a0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511702, encodeId=57b11511e0256, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=J Am Heart Assoc：房颤患者二级预防：直接口服抗凝药vs维生素K拮抗剂, objectType=article, longId=136601, objectId=5f5d136601ff, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5f5d136601ff, replyNumber=0, likeNumber=59, createdTime=2018-04-28, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5f5d136601ff, moduleTitle=J Am Heart Assoc：房颤患者二级预防：直接口服抗凝药vs维生素K拮抗剂, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5f5d136601ff)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

拮抗剂

2020-05-29

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

Eur Heart J：导管消融房颤之前何时停止非维生素K拮抗剂口服抗凝药？

2019-01-02

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

Clinical Gastro H：长期接受肿瘤坏死因子拮抗剂治疗的患者乙型肝炎病毒再激活和肝毒性的发生率

2018-12-11

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

Chest：肥厚型心肌病合并房颤患者服用非维生素K拮抗剂的疗效和安全性

2018-11-25

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

JAMA Intern Med：醛固酮受体拮抗剂或可有助于STEMI治疗

2018-10-11

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

血管紧张素Ⅱ受体拮抗剂在冠心病患者中的临床应用建议（2018）

2018-09-25

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

Stroke：非维生素K拮抗剂口服抗凝药降低房颤患者卒中风险再添新证

2018-09-19

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

JACC：口服维生素K拮抗剂房颤患者的预后研究

2018-09-17

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

Chest：溶血磷脂酸受体1拮抗剂用于治疗特发性肺纤维化的疗效

2018-09-11

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

JAHA：维生素K拮抗剂的摄入会增加心血管疾病风险

2018-08-31

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

Med Sci Monit：ATN-161作为整合素α5β1拮抗剂通过促进新生血管内皮细胞凋亡抑制眼部新生血管形成

2018-08-30

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

JAMA Cardiol：腹部肥胖患者使用盐皮质激素受体拮抗剂效果更佳

2018-08-25

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

Clin Gastroenterol Hepatol：肝硬化门静脉血栓形成服用维生素K拮抗剂出血风险知多少？

2018-08-05

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

FDA批准**口服促性腺激素释放激素拮抗剂用于治疗子宫内膜异位症

2018-07-28

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

JAHA：盐皮质激素受体拮抗剂可改善部分心梗和心衰患者预后

2018-07-09

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

降压药分子长效钙拮抗剂都包含哪些药？

2018-06-26

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

JAMA Inter Med：无心衰ST段抬高型心梗：醛固酮受体拮抗剂也有获益

2018-06-03

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

Fertil Steril：体外受精：GnRH拮抗剂治疗的更佳起始条件

2018-05-26

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

Liver Int：盐皮质激素受体拮抗剂—eplerenone，可能不是治疗人类免疫缺陷病毒感染人群肝脂肪变性的有效方法

2018-05-15

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

Hepatology：CC趋化因子受体拮抗剂能够改善NASH患者的肝纤维化

2018-05-10

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

J Am Heart Assoc：房颤患者二级预防：直接口服抗凝药vs维生素K拮抗剂

2018-04-28

科室
- - 订阅+
  - 更多科室
工具
服务